Abstract:Background Acute penetrating aortic ulcers (PAUs) are reported to dynamically evolve into different clinical outcomes ranging from regression to aortic rupture, but no practice guidelines are available in China. Methods and Results All 109 patients with acute PAUs were monitored clinically. At 30 days follow‐up, 31 patients (28.44%) suffered from aortic‐related adverse events, a composite of aortic‐related mortality, aortic dissection, or an enlarged ulcer. In addition, 7 (6.42%) patients had clinically related adverse events, including all‐cause mortality, cerebral stroke, nonfatal myocardial infarction, acute heart failure alone or acute exacerbation of chronic heart failure, acute renal failure, arrhythmia, and bleeding events. In the present study, the intervention criteria for the Chinese PAU population included a PAU diameter of 12.5 mm and depth of 9.5 mm. The multivariate analysis showed that an ulcer diameter >12.5 mm (hazard ratio [HR], 3.846; 95% CI, 1.561–9.476; P =0.003) and an ulcer depth >9.5 mm (HR, 3.359; 95% CI, 1.505–7.494; P =0.003) were each independent predictors of aortic‐related events. Conclusions Patients with acute PAUs were at high risk for aortic‐related adverse events and clinically related adverse events within 30 days after onset. Patients with an ulcer diameter >12.5 mm or an ulcer depth >9.5 mm have a higher risk for disease progression, and early intervention may be recommended. Nonstandard Abbreviations and Acronyms AAS acute aortic syndrome AD aortic dissection EVAR endovascular repair PAUs penetrating aortic ulcers Clinical Perspective What Is New? The first penetrating aortic ulcer intervention criteria for the Chinese patients were 12.5 mm for ulcer diameter and 9.5 mm for ulcer depth. What Are the Clinical Implications? Patients with acute penetrating aortic ulcers were at high risk for aortic‐related adverse events and clinically related adverse events within 30 days after onset. Patients with an ulcer diameter >12.5 mm or an ulcer depth >9.5 mm have a higher risk for disease progression, and early intervention may be recommended. In aortic diseases, both penetrating aortic ulcers (PAUs) and aortic dissection (AD) are classified as acute aortic syndrome (AAS). 1 PAUs account for 2% to 7% of AAS cases and may deteriorate to AD, aneurysm formation, and aortic rupture. 2 The etiology of the PAU is not clear and may be related to an atheromatous plaque that disrupts the internal elastic lamina without a false lumen. 3 The PAU, a special type of AAS 4 that is similar to AD and intramural hematoma in terms of its clinical manifestation, has unique pathological features and clinical outcomes that are different from those of other types of AAS. 5 Furthermore, the long‐term evolution of the PAU is unclear. The American guidelines recommend endovascular repair (EVAR) for asymptomatic PAU (III C) and symptomatic PAU (II b C). 6 The European guidelines recognize PAU as a type of AAS with a surgical indication (II b C). For type B PAU, the European guidelines suggest medical treatment (I C), but complicated type B PAU may be considered for EVAR (II a C) or surgery (II b C). 7 There are only a few case reports of PAUs, and the amount of detailed, large‐scale, real‐world clinical data reported for Chinese patients with PAUs is small. Thus, the present study aims to examine the imaging characteristics and clinical prognoses of PAUs and to explore the predictors of aortic‐related adverse events in cases of acute PAUs. METHODS This study was a non‐interventional retrospective and observational clinical data analysis study. It has been reviewed and approved by the eth -Abstract Truncated-

Long-term Follow-Up and Clinical Implications in Chinese Patients with Aortic Intramural Hematomas

Early Aggressive Medical Treatment Associated with Selective Prophylactic Aortic Stent-Grafting for Aortic Intramural Hematoma

Acute Type B Aortic Intramural Hematoma: Treatment Strategy And The Role Of Endovascular Repair

A radiomics model based on aortic computed tomography angiography: the impact on predicting the prognosis of patients with aortic intramural hematoma (IMH)

Treatment of acute type B intramural hematoma of the aorta

Relationship Between White-Matter Hyperintensities and Hematoma Volume and Growth in Patients with Intracerebral Hemorrhage

Clinical characteristics and prognostic value of focal enhancement on computed tomography angiography in patients with acute type B aortic intramural hematoma

The treatment choice and outcome of aortic intramural hematoma

Clinical Features and Outcomes after Endovascular Therapy for Penetrating Aortic Ulcer and Intramural Hematoma.

Survival and aortic remodeling outcomes in patients with type B aortic intramural hematoma in the endovascular era: an observational cohort study

A nomogram prediction model for short-term aortic-related adverse events in patients with acute Stanford type B aortic intramural hematoma: development and validation

Prognostic Implications of Initial Focal Contrast Enhancement in Acute Type B Intramural Hematoma

Clinical analysis of acute type A intramural hematoma: comparison between two different pathophysiological types

Comparison of surgical and conservative treatment outcomes for type a aortic intramural hematoma

A single-center experience of type B aortic intramural hematoma

Initial thickness of the crescent may not be a reliable predictor of complications in type A intramural haematoma

Outcomes of intramural hematoma involving the ascending aorta and extending into the descending thoracic aorta

Acute Type A Intramural Hematoma: The Less Deadly Acute Aortic Syndrome?

Population-Based Assessment of Aortic-Related Outcomes in Aortic Dissection, Intramural Hematoma, and Penetrating Aortic Ulcer

Timing of Intervention and Long-Term Outcomes of Type B Aortic Intramural Hematoma with Intimal Disruption at Admission.

Long-Term Imaging Evolution and Clinical Prognosis Among Patients With Acute Penetrating Aortic Ulcers: A Retrospective Observational Study.